Drug Shortage Report for ADENOSINE INJECTION

Last updated on 2021-11-04 History
Report ID 145130
Drug Identification Number 02267659
Brand name ADENOSINE INJECTION
Common or Proper name Adenosine Injection 3 mg/mL SD Vial 2 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ADENOSINE
Strength(s) 3MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2 mL Vial
ATC code C01EB
ATC description OTHER CARDIAC PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-09-10
Actual start date
Estimated end date 2021-11-03
Actual end date 2021-11-03
Shortage status Resolved
Updated date 2021-11-04
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-11-04 English Compare
v9 2021-11-03 French Compare
v8 2021-11-03 English Compare
v7 2021-10-29 French Compare
v6 2021-10-29 English Compare
v5 2021-10-01 French Compare
v4 2021-10-01 English Compare
v3 2021-09-11 English Compare
v2 2021-09-02 French Compare
v1 2021-09-02 English Compare